Dr Hussein Farghaly PSMMC

Slides:



Advertisements
Similar presentations
The Memory Assessment and Treatment Service (MATS)
Advertisements

Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
© Copyright 2004 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. Brain Anatomy and Function.
Frontotemporal Dementia
Martha Stearn, MD Institute for Cognitive Health St John’s Medical Center Jackson, Wyoming.
SPECT imaging in cerebrovascular disease Measurement of regional cerebral blood flow (rCBF) Sensitive indicator of perfusion Diagnosis and prognosis of.
Unforgettable images: A multimodality pictorial review of dementia
Dementia with Lewy Bodies
Jeffrey Cummings, MD Mary S. Easton Center for Alzheimer’s Disease Research Deane F. Johnson Center for Neurotherapeutics David Geffen School of Medicine.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
M. Alzheimer. Etiopatogenesis patological proteins u neuritic plaques u  amyloid u amyloid precursor protein (APP)  sekretase  sekretase  amyloid.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part A – AD definition, neuropath? NUCLEAR MEDICINE GRAND.
ORGANIC MENTAL DISORDERS Maria L.A. Tiamson, MD Asst. Professor, Psychiatry New York Medical College.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Burcu Ormeci, MD Department of Neurology.  In the United States;  As many as 7 million people have dementia  Almost half of all people age 85 and older.
Methodological Issues 4 Age effects - the consequence of being a given chronological age 4 Cohort effects - the consequences of having been born in a given.
Cognitive Impairment Disorders. Assessing Brain Damage  Mental status examination  Information about current behavior and thought including orientation.
Clear organic causes, where primary symptom is a significant deficit in cognitive ability changes in the person’s personality and behavior (due to the.
Imaging Degenerative Diseases of the Brain Cathleen Kouvolo.
Jack Twersky, MD Medical Director CLC Durham.  Memory impairment and at least one of the following  Aphasia  Apraxia  Agnosia  Executive function.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
 Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer’s is the most common form of dementia. This.
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part C – AD brain scans - anatomical NUCLEAR MEDICINE GRAND.
Dementia 痴呆 Jie Ming Shen, M.D., Ph.D. Department of Neurology Ruijin Hospital, SSMU.
Dr Hussein Farghaly PSMMC Radionuclide Brain Imaging Master Watermark Image:
How to diagnose dementia? Dr. Sridhar Vaitheswaran 25 th October 2012.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
Wei Chen CCNI Journal Club Alzheimer’s disease (AD): imaging & cognition imaging & cognition.
Jalal Jalal Shokouhi – MD
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Epidemiology of Alzheimer’s Disease
High resolution MRI at 21.1 T of the hippocampus and temporal lobe white matter in the differential classification of Alzheimer’s Disease & Diffuse Lewy.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Central Nervous System
Mariano Musacchio 1 François Sellal 2 Frédéric Blanc 2 Jean-Marc Michel 2 Stephan Kremer 3 Jean-Louis Dietemann 3 1 Department of Neuroradiology - CHG.
Brain and Behavior O RGANIZATION OF THE C EREBRAL C ORTEX Gray matter –Cell bodies and dendrites Most common type: Pyramidal cells –Organized.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Alzheimer’s Disease Stephanie Aparicio May 4, 2011 Period 5.
Orientation to Early Memory Loss. Let’s look for some answers… What is happening? What should I do? Where should I go?
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
Frontotemporal Lobar Degeneration:
This is an umbrella term, not a disease in its own right. It is a term used for a large group of symptoms that adversely affect the brain and can be caused.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
The Malfunctioning Mind: Degenerative Diseases of the Brain
Dementia with Lewy Bodies
Radiological imaging of dementia.
Rosa Maria Moresco University of Milan Bicocca
Brain Anatomy and Function
by: Prof.Dr. Hosna Moustafa Cairo University, Egypt
Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,
Image Challenge Q: A 70-year-old woman presented to the neurology clinic with a 2-year history of gait disturbance, cognitive impairment, and urinary incontinence.
Volume 21, Issue 4, Pages xv-xxiii (December 1998)
Imaging AD Progression Amyloid Imaging Agents.
Temporal associational cortex
Brain Tech TIME Case Study: FDG PET IMAGING IN DEMENTIA (FTD vs AD)
Keith A. Josephs, MD, MST, MSc  Mayo Clinic Proceedings 
Coronal (above) and axial (below) views of brain imaging findings in selected young onset dementias (images reproduced by kind permission of Dr Hadi Manji.
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
Probing the Biology of Alzheimer's Disease in Mice
Chapter 93 Dementias and Related Disorders
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
A patient with early Alzheimer disease, 77 years of age, Mini-Mental State Examination score = 25. A patient with early Alzheimer disease, 77 years of.
Biomarker Modeling of Alzheimer’s Disease
Patient 2- Alzheimer’s Disease
The Memory Assessment and Treatment Service (MATS)
Axial MR image (TR/TE, 10,002/142) obtained when the patient was aged 5 days shows extensive areas of abnormal signal intensity, which suggest edema involving.
Presentation transcript:

Dr Hussein Farghaly PSMMC Radionuclide Brain Imaging Lecture 5 Dr Hussein Farghaly PSMMC Master Watermark Image: http://williamcalvin.com/BrainForAllSeasons/img/bonoboLH-humanLH-viaTWD.gif

Dementia: An acquired syndrome characterized by: Short-term memory impairment AND At least one of the following: Aphasia - language impairments Apraxia - motor memory impairments Agnosia - sensory memory impairments Abstract thinking / Exec. function impairments Impairment in social and/or occupational fn Not explainable by another disorder

Causes of Dementia Dementia is a manifestation of many diseases. Only about 10% of dementias, such as those caused by vitamin B12 or thyroid hormone deficiency, are treatable

Causes of Dementia Alzheimer Disease (50-70%) Vascular dementia (15%) Frontotemporal dementia (5-10%) Lewy Body disease (25%) Normal Pressure Hydrocephalus (NPH) Depression Intracranial Mass

Diagnosis of Dementia The clinical diagnosis is often difficult and delayed, and anatomical imaging modalities such as CT and MRI may not reveal changes such as atrophy until the end stages of disease. SPECT and PET, on the other hand, have been shown useful in early diagnosis of Alzheimer disease. In addition, these functional modalities show promise for the identification of subjects early before damage is too severe for therapy to have any benefit. Although PET has higher sensitivity and higher resolution than SPECT, the overall patterns seen in dementia are similar for both rCGM and rCBF. In general, the types of dementia can be characterized as posterior, frontotemporal, or vascular. The posterior dementias include Alzheimer disease, Lewy body disease, and Parkinson dementia. Pick disease is the classic frontotemporal dementia.

Alzheimer’s Disease (AD) Progressive neurodegenerative disorder deterioration in cognition, function, and behavior Most common cause dementia in elderly 4 million in U.S. 30 million worldwide Female to male 3:1 $100 billion per year in U.S.

Pathology and Etiology Initial damage of neurons in temporal lobes and later in neocortex Extracellular beta amyloid plaques and intracellular neurofibrillary tangles (tau protein) Plaque buildup induces inflamation causing injury in hippocampus and cerebral cortex

Clinical Diagnosis Accuracy can exceed 90% Detailed history, physical, mental status examination, and neurologic assessment Rule out hypothyroidism, vitamin B12 deficiency, reversible causes of dementia

Imaging Studies Stuctural: CT and MR recommended for routine evaluation of AD Functional: PET and SPECT demonstrate physiologic changes in brain

MR vs. CT Low specificy and sensitivity MR preferred over CT Assess degree of Medial Temporal Lobe Atrophy Amygdala, Hippocampus, Parahippocampal gyrus Rule out other causes dementia

AD vs. Other Dementias NPH: holoventricular enlargement out of proportion to sulcal enlargement; dementia, apraxia, incontinence Generalized atrophy: sulcal and ventricular findings concordant Vascular dementia: multiple areas of high signal intensity on MR; stepwise decline, smokers, HTN, diabetes

Functional Imaging Modalities SPECT and PET Vascular dementia Frontotemporal dementia Lewy Body depression

SPECT imaging Brain uptake of technetium 99m-based lipid-soluble radionuclide 89% sensitivity and 80% specificity for AD Bilateral posterior perfusion abnormality associated with AD Frontal perfusion deficit associated with frontotemporal dementia Patchy uptake pattern associated with vascular dementia

SPECT imaging

Alzheimer Disease VS. Lewy Body disease AD LB Comparison of posterior dementias on Tc-99m HMPAO. Top row: Alzheimer disease generally begins near the superior convexity and involves the parietal and temporal regions laterally (arrows), sparing the occiput and cerebellum (arrowhead). Bottom row: Lewy body disease involves the medial occipital region (arrows) and usually has more caudal extension than Alzheimer disease. Nuclear Medicine: The Requisites textbook

PET imaging FDG and blood flow Deficits in temporoparietal metabolism seen in patients with AD Sparing of basal ganglia, thalamus, cerebellum, and primary sensorimotor complex Sensitivity 87-96%, 73% specificity

Alzheimer disease (A) Transaxial PET images reveal decreased metabolism to the temporal parietal cortex beginning high in the posterior parietal region with sparring of the basal ganglia, thalamus, and cerebellum. Nuclear Medicine: The Requisites textbook

(B) Tc-99m HMPAO SPECT shows that although Alzheimer disease is classically described as a symmetric process, it may be quite asymmetric, as seen in the left posterior parietal region. Nuclear Medicine: The Requisites textbook

(C) As Alzheimer disease becomes more severe it is more diffuse on this SPECT study. Nuclear Medicine: The Requisites textbook

PET imaging Frontotemporal dementias: decreased uptake in frontal and anterior temporal regions Depression: normal scan Vascular: patchy defects in central white matter Lewy body: deficits in occipital lobes and cerebellum

Frontotemporal Dementia

Frontotemporal dementia sparing posterior parietal regions. A, Frontal hypometabolism on PET can be due to many causes and changes visible long before MRI Nuclear Medicine: The Requisites textbook

AD

MID

FTD

Amyloid PET imaging New tracer for PET Carbon-11 (C-11)-labeled Pittsburgh compound B (PiB), Ab—or amyloid PET [F-18]florbetapir, achieved approval by the U.S. Food and Drug Administration in April 2012 Targets amyloid beta senile plaques and neurofibrillary tangles Long retention times in hippocampus

References Jack CR et al. MR Imaging-Based Volume Measurements of the Hippocampal Formation and Anterior Temporal Lobe: Validation Studies. Neuroradiology. Volume 176. No. 1; pp. 205-209. Lehericy et al. Magnetic Resonance Imaging of Alzheimer’s Disease. Eur Radiol (2007) 17: 347-362. Petrella, et al. Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future. Radiology 2003; 226: 315-336. Zakzanis, Graham, and Campbell. A Meta-Analysis of Structural and Functional Brain Imaging in Dementia of the Alzheimer’s Type: A Neuroimaging Profile. Neuropsychology Review, Vol. 13, No. 1, March 2003.